NCT Number: NCT00890370
Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?
The study was to evaluate the long term effects, over one year, of five airway clearance techniques used by people with cystic fibrosis (active cycle of breathing techniques, autogenic drainage, positive expiratory pressure and oscillating positive expiratory pressure (R-C Cornet and Flutter)). The primary outcome measure was forced expiratory volume in one second (FEV1)and the null hypothesis was that there are no differences among the regimens.
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosis of cystic fibrosis (genotype or sweat sodium concentration greater than 70 mmol/litre)
- Forced expiratory volume in one second greater than or equal to 25% predicted, on assessment for entry to the study.
Exclusion criteria
- Evidence of a current respiratory exacerbation (Thornton et al 2004)
- Current severe haemoptysis
- Past history of pneumothorax
- Awaiting lung / heart-lung transplantation
- Pregnancy
- Recent (within 3 months) acquisition of Burkholderia cepacia
Treatment and study plan
Primary outcomes
-
Forced expiratory volume in one second (FEV1)
Time frame: 48 weeks
Secondary outcomes
-
Quality of life (Short Form-36 and Chronic Respiratory Questionnaire)
Time frame: 48 weeks
-
Exercise capacity (Modified shuttle test)
Time frame: 48 weeks
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Other
Registry information
Official study title
A Comparison of Five Airway Clearance Techniques in the Treatment of Adults With Cystic Fibrosis
Acronym: ACT
Important dates
- Study start
- 1999
- Primary completion
- 2003
- Study completion
- 2003
- First posted
- Apr 29, 2009
- Registry last updated
- Apr 29, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Denver, Colorado, United States
View Trial DetailsEvaluation of Lung T1-MRI in Pediatric Cystic Fibrosis Patients
NCT04994301
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Indianapolis, Indiana, United States
View Trial DetailsComparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation
NCT04673331
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Ankara, Turkey (Türkiye)
View Trial DetailsSildenafil Exercise: Role of PDE5 Inhibition
NCT04039087
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Denver, Colorado, United States
View Trial Details